Avalo Therapeutics Inc (AVTX)
12.20
+0.57
(+4.90%)
USD |
NASDAQ |
Apr 22, 16:00
12.25
+0.05
(+0.41%)
After-Hours: 20:00
Avalo Therapeutics Max Drawdown (5Y): 99.98% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.98% |
| February 29, 2024 | 99.98% |
| January 31, 2024 | 99.98% |
| December 31, 2023 | 99.96% |
| November 30, 2023 | 99.92% |
| October 31, 2023 | 99.90% |
| September 30, 2023 | 99.90% |
| August 31, 2023 | 99.90% |
| July 31, 2023 | 99.78% |
| June 30, 2023 | 99.59% |
| May 31, 2023 | 98.14% |
| April 30, 2023 | 98.14% |
| March 31, 2023 | 98.14% |
| February 28, 2023 | 97.09% |
| January 31, 2023 | 96.58% |
| December 31, 2022 | 96.58% |
| November 30, 2022 | 96.58% |
| October 31, 2022 | 96.58% |
| September 30, 2022 | 96.58% |
| August 31, 2022 | 96.54% |
| July 31, 2022 | 96.54% |
| June 30, 2022 | 96.54% |
| May 31, 2022 | 96.54% |
| April 30, 2022 | 94.31% |
| March 31, 2022 | 91.25% |
| Date | Value |
|---|---|
| February 28, 2022 | 90.83% |
| January 31, 2022 | 91.55% |
| December 31, 2021 | 91.55% |
| November 30, 2021 | 91.55% |
| October 31, 2021 | 91.55% |
| September 30, 2021 | 91.55% |
| August 31, 2021 | 91.55% |
| July 31, 2021 | 91.55% |
| June 30, 2021 | 91.55% |
| May 31, 2021 | 91.55% |
| April 30, 2021 | 91.55% |
| March 31, 2021 | 91.55% |
| February 28, 2021 | 91.55% |
| January 31, 2021 | 91.55% |
| December 31, 2020 | 91.55% |
| November 30, 2020 | 91.55% |
| October 31, 2020 | 91.55% |
| September 30, 2020 | 91.55% |
| August 31, 2020 | 91.55% |
| July 31, 2020 | 91.55% |
| June 30, 2020 | 91.55% |
| May 31, 2020 | 91.55% |
| April 30, 2020 | 91.55% |
| March 31, 2020 | 91.55% |
| February 29, 2020 | 91.55% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.83%
Minimum
Feb 2022
99.98%
Maximum
Jan 2024
94.14%
Average
91.55%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
| Imunon Inc | 99.38% |
| iBio Inc | 99.97% |
| Kodiak Sciences Inc | 99.15% |
| Petros Pharmaceuticals Inc | -- |
| Ocugen Inc | 99.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -90.59 |
| Beta (5Y) | 1.152 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 118.9% |
| Historical Sharpe Ratio (5Y) | -0.6354 |
| Historical Sortino (5Y) | -1.124 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 53.13% |